Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: A meta-analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Poolsup, Nalinee ^a   Suksomboon, Naeti ^b   Amin, Muhammad ^b  

^a SILPAKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

ARTICLE; CESAREAN SECTION; CONGENITAL DISORDER; DRUG EFFICACY; DRUG SAFETY; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HIGH RISK PREGNANCY; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LABOR INDUCTION; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL HYPERTENSION; MATERNAL HYPOGLYCEMIA; META ANALYSIS; NEONATAL HYPOGLYCEMIA; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SHOULDER DYSTOCIA; SMALL FOR DATE INFANT; COMPARATIVE STUDY; DIABETES, GESTATIONAL; FEMALE; PREGNANCY; TREATMENT OUTCOME;

DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PREGNANCY; TREATMENT OUTCOME;

EID: 84907907063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109985     Document Type: Article

References (48)

1. American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus, (Position Statement). Diabetes Care 36 (Suppl. 1): s67-s74.
2. Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25: 1862-1868.
3. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991-2002.
4. Ju H, Rumbold AR, Willson KJ, Crowther CA (2008) Borderline gestational diabetes mellitus and pregnancy outcomes. BMC Pregnancy Childbirth 8: 31.
5. Langer O, Yogev Y, Most O, Xenakis EM (2005) Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 192: 989-997.
6. Henriksen T (2008) The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 87: 134-145.
7. Reece EA, Leguizamon G, Wiznitzer A (2009) Gestational diabetes: the need for a common ground. Lancet 373: 1789-1797.
8. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, et al. (2007) Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 30: 2287-2292.
9. Slining M, Adair LS, Goldman BD, Borja JB, Bentley M (2010) Infant overweight is associated with delayed motor development. J Pediatr 157: 20-25 e21.
10. Ornoy A (2005) Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev 3: 104-113.
11. Forman MR CM, Ronckers C, Zhang Y. (2005) Through the looking glass at early-life exposures and breast cancer risk. Cancer Invest 23: 609-624.
12. Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335: 974.
13. National Institute for Health and Clinical Excellence London (2008) Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period [www.nice.org.uk/CG063].
14. The American College of Obstetricians and Gynecologists (2013) Gestational diabetes mellitus: Clinical management guidelines for obstetricians-gynecologists. Obstet Gynecol 122: 406-416.
15. Dhulkotia JS, Ola B, Fraser R, Farrell T (2010) Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol 203: 457 e451-459.
16. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, et al. (2009) Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 113: 193-205.
17. Higgins JPT, editor Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011.
18. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
19. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
20. Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, et al. (2011) Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 118: 880-885.
21. Moore LE, Briery CM, Clokey D, Martin RW, Williford NJ, et al. (2007) Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J Reprod Med 52: 1011-1015.
22. Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, et al. (2012) Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pract 98: 422-429.
23. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358: 2003-2015.
24. Spaulonci CP, Bernardes LS, Trindade TC, Zugaib M, Francisco RP (2013) Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol 209: 34 e31-37.
25. Tertti K, Ekblad U, Koskinen P, Vahlberg T, Ronnemaa T (2013) Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab 15: 246-251.
26. Anjalakshi C, Balaji V, Balaji MS, Seshiah V (2007) A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 76: 474-475.
27. Bertini AM, Silva JC, Taborda W, Becker F, Lemos Bebber FR, et al. (2005) Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 33: 519-523.
28. Lain KY, Garabedian MJ, Daftary A, Jeyabalan A (2009) Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol 200: 501 e501-506.
29. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O (2000) A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343: 1134-1138.
30. Ogunyemi D, Jesse M, Davidson M (2007) Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract 13: 427-428.
31. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, et al. (2007) [Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin]. Arq Bras Endocrinol Metabol 51: 541-546.
32. Tempe A, Mayanglambam RD (2013) Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res 39: 1147-1152.
33. Sadeh-Mestechkin D, Walfisch A, Shachar R, Shoham-Vardi I, Vardi H, et al. (2008) Suspected macrosomia? Better not tell. Arch Gynecol Obstet 278: 225-230.
34. Kemball ML, McIver C, Milner RD, Nourse CH, Schiff D, et al. (1970) Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child 45: 696-701.
35. Douglas CP, Richards R (1967) Use of chlorpropamide in the treatment of diabetes in pregnancy. Diabetes 16: 60-61.
36. Charles B, Norris R, Xiao X, Hague W (2006) Population pharmacokinetics of metformin in late pregnancy. Ther Drug Monit 28: 67-72.
37. Gilbert C, Valois M, Koren G (2006) Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 86: 658-663.
38. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L (2002) Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17: 2858-2864.
39. Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T (1994) Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 171: 653-660.
40. Gui J, Liu Q, Feng L (2013) Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One 8: e64585.
41. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, et al. (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 122: 253-270.
42. Vanky E, F DEZ, Diaz M, Ibanez L, Carlsen SM (2012) On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis. Acta Obstet Gynecol Scand 91: 1460-1464.
43. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, et al. (2004) Height, weight, and motor±social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human Reproduction 19: 1323-1330.
44. Jovanovic-Peterson L, Kitzmiller JL, Peterson CM (1992) Randomized trial of human versus animal species insulin in diabetic pregnant women: improved glycemic control, not fewer antibodies to insulin, influences birth weight. Am J Obstet Gynecol 167: 1325-1330.
45. Pedersen J (1954) Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 16: 330-342.
46. Langer O, Yogev Y, Xenakis EM, Brustman L (2005) Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol 192: 1768-1776.
47. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, et al. (2009) Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 85: 607-614.
48. Zeng YC, Li MJ, Chen Y, Jiang L, Wang SM, et al. (2014) The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci 59: 95-101.